221 related articles for article (PubMed ID: 30825715)
21. Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.
Lusardi M; Signorello MG; Russo E; Caviglia D; Ponassi M; Iervasi E; Rosano C; Brullo C; Spallarossa A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731825
[TBL] [Abstract][Full Text] [Related]
22. Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation.
Eldehna WM; Abo-Ashour MF; Ibrahim HS; Al-Ansary GH; Ghabbour HA; Elaasser MM; Ahmed HYA; Safwat NA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):686-700. PubMed ID: 29560733
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and preliminary evaluation of 3-thiocyanato-1H-indoles as potential anticancer agents.
Fortes MP; da Silva PB; da Silva TG; Kaufman TS; Militão GC; Silveira CC
Eur J Med Chem; 2016 Aug; 118():21-6. PubMed ID: 27116711
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
H Al Rasheed HHA; M Malebari AM; A Dahlous KA; El-Faham A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32545272
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in silico studies of antioxidant activity of 2-thiazolylhydrazone derivatives.
Maltarollo VG; Resende MF; Kronenberger T; Lino CI; Sampaio MCPD; Pitta MGDR; Rêgo MJBM; Labanca RA; Oliveira RB
J Mol Graph Model; 2019 Jan; 86():106-112. PubMed ID: 30347318
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives.
Sreenivasulu R; Reddy KT; Sujitha P; Kumar CG; Raju RR
Bioorg Med Chem; 2019 Mar; 27(6):1043-1055. PubMed ID: 30773423
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.
Youssif BGM; Abdelrahman MH; Abdelazeem AH; Abdelgawad MA; Ibrahim HM; Salem OIA; Mohamed MFA; Treambleau L; Bukhari SNA
Eur J Med Chem; 2018 Feb; 146():260-273. PubMed ID: 29407956
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha-(N)-acyl heteroaromatics.
Easmon J; Pürstinger G; Thies KS; Heinisch G; Hofmann J
J Med Chem; 2006 Oct; 49(21):6343-50. PubMed ID: 17034140
[TBL] [Abstract][Full Text] [Related]
29. Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
More KN; Jang HW; Hong VS; Lee J
Bioorg Med Chem Lett; 2014 Jun; 24(11):2424-8. PubMed ID: 24775304
[TBL] [Abstract][Full Text] [Related]
30. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of New Hydrazone Derivatives and Evaluation of their Efficacy as Proliferation Inhibitors in Human Cancer Cells.
Świątek P; Saczko J; Rembiałkowska N; Kulbacka J
Med Chem; 2019; 15(8):903-910. PubMed ID: 30686263
[TBL] [Abstract][Full Text] [Related]
32. Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis.
Bramson HN; Corona J; Davis ST; Dickerson SH; Edelstein M; Frye SV; Gampe RT; Harris PA; Hassell A; Holmes WD; Hunter RN; Lackey KE; Lovejoy B; Luzzio MJ; Montana V; Rocque WJ; Rusnak D; Shewchuk L; Veal JM; Walker DH; Kuyper LF
J Med Chem; 2001 Dec; 44(25):4339-58. PubMed ID: 11728181
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and pharmacophoric model building of novel substituted nicotinic acid hydrazones with potential antiproliferative activity.
Abdel-Aziz HA; Aboul-Fadl T; Al-Obaid AR; Ghazzali M; Al-Dhfyan A; Contini A
Arch Pharm Res; 2012 Sep; 35(9):1543-52. PubMed ID: 23054710
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, antioxidant and DNA cleavage activities of novel indole derivatives.
Biradar JS; Sasidhar BS; Parveen R
Eur J Med Chem; 2010 Sep; 45(9):4074-8. PubMed ID: 20594623
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives.
Sinicropi MS; Caruso A; Conforti F; Marrelli M; El Kashef H; Lancelot JC; Rault S; Statti GA; Menichini F
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1148-53. PubMed ID: 19555184
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferative activity of [1,2,3,5]tetrazino[5,4-a]indoles, a new class of azolo-tetrazinones.
Barraja P; Diana P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2005 Jan; 13(2):295-300. PubMed ID: 15598552
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
40. Antitumor effects of synthetic 6,7-annulated-4-substituted indole compounds in L1210 leukemic cells in vitro.
Perchellet JP; Waters AM; Perchellet EM; Thornton PD; Brown N; Hill D; Neuenswander B; Lushington GH; Santini C; Chandrasoma N; Buszek KR
Anticancer Res; 2012 Nov; 32(11):4671-84. PubMed ID: 23155229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
